食管胃交界部肿瘤的外科治疗
Surgical management of esophagogastric junction tumors.
作者信息
von Rahden Burkhard H A, Stein Hubert J, Siewert J Rüdiger
机构信息
Department of Surgery, Technische Universitat Munchen, Ismaningerstr 22, Munchen D-81675, Germany.
出版信息
World J Gastroenterol. 2006 Nov 7;12(41):6608-13. doi: 10.3748/wjg.v12.i41.6608.
Abstract
Surgical resection with lymphadenectomy is the mainstay of treatment for all resectable esophagogastric junction tumors, prior to systemic generalization of the disease. This makes accurate pre-treatment staging and classification of the tumors most demanding. A well-established and internationally accepted classification for adenocarcinomas of the esophagogastric junction (AEG) helps to choose the appropriate surgical approach and to make results from different institutions comparable. Distal esophageal adenocarcinomas (AEG I) are distinguished from true cardia carcinomas (AEG II) and subcardiac gastric cancers (AEG III). Substantial advancements in this surgical field during the preceding decades have clearly revealed that individualization of the surgical strategy is the key to successfully approaching these entities. In this review we discuss the surgical management of esophagogastric junction tumors with a tailored surgical strategy.
摘要
在疾病发生全身转移之前，手术切除加淋巴结清扫是所有可切除的食管胃交界部肿瘤的主要治疗方法。这使得肿瘤的准确术前分期和分类成为最迫切的需求。一种成熟且国际公认的食管胃交界部腺癌（AEG）分类有助于选择合适的手术方法，并使不同机构的结果具有可比性。远端食管腺癌（AEG I）与真性贲门癌（AEG II）和贲门下胃癌（AEG III）相区分。在过去几十年中，该手术领域取得了重大进展，清楚地表明手术策略的个体化是成功处理这些疾病的关键。在本综述中，我们将讨论采用定制手术策略对食管胃交界部肿瘤进行手术管理。
相似文献
1
Surgical management of esophagogastric junction tumors.食管胃交界部肿瘤的外科治疗
World J Gastroenterol. 2006 Nov 7;12(41):6608-13. doi: 10.3748/wjg.v12.i41.6608.
2
Cancer of the esophagogastric junction.食管胃交界部癌
Surg Oncol. 2000 Jul;9(1):35-41. doi: 10.1016/s0960-7404(00)00021-9.
3
Individualized surgical strategies for cancer of the esophagogastric junction.食管胃交界部癌的个体化手术策略
Ann Chir Gynaecol. 2000;89(3):191-8.
4
Surgical resection for cancer of the cardia.贲门癌的手术切除
Semin Surg Oncol. 1999 Sep;17(2):125-31. doi: 10.1002/(sici)1098-2388(199909)17:2<125::aid-ssu7>3.0.co;2-9.
5
Results of surgical therapy of adenocarcinomas of the esophagogastric junction according to a standardized surgical resection technique.根据标准化手术切除技术对食管胃交界腺癌进行手术治疗的结果。
Dig Surg. 2002;19(4):269-74; discussion 275. doi: 10.1159/000064579.
6
Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.食管胃交界腺癌：基于解剖学/地形学分类的手术治疗结果——1002例连续患者分析
Ann Surg. 2000 Sep;232(3):353-61. doi: 10.1097/00000658-200009000-00007.
7
[Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction].[现代诊断与分期导向手术：食管胃交界腺癌的治疗]
Chirurg. 2012 Aug;83(8):702-8, 710-1. doi: 10.1007/s00104-011-2264-8.
8
Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.食管胃交界腺癌：基于1602例连续切除患者的手术治疗
Surg Oncol Clin N Am. 2006 Oct;15(4):751-64. doi: 10.1016/j.soc.2006.07.015.
9
Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.胃食管交界部癌的分类、诊断及外科治疗
Hepatogastroenterology. 2001 Sep-Oct;48(41):1231-7.
10
Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma.对于早期食管胃交界腺癌，纵隔淋巴结清扫和远端食管切除术并非必要。
World J Surg Oncol. 2017 Jan 18;15(1):28. doi: 10.1186/s12957-016-1088-x.
引用本文的文献
1
Prognostic Implications of Various Surgical Procedures and Postoperative Margin Status in Gastroesophageal Junction Tumors.各种手术方式及切缘状态对胃食管交界部肿瘤的预后影响
Indian J Surg Oncol. 2024 Mar;15(1):12-17. doi: 10.1007/s13193-023-01821-w. Epub 2023 Sep 23.
2
Total laparoscopic total gastrectomy and distal esophagectomy combined with reconstruction by transhiatal esophagojejunal Roux-en-y mediastinal anastomosis for Siewert II AEG.全腹腔镜全胃切除术和食管下段切除术联合经食管裂孔食管空肠 Roux-en-y 纵隔吻合术治疗 Siewert II 型胃食管结合部腺癌。
J Cardiothorac Surg. 2023 Nov 22;18(1):339. doi: 10.1186/s13019-023-02453-5.
3
Gross tumor volume of adenocarcinoma of esophagogastric junction corresponding to cT and cN stages measured with computed tomography to quantitatively determine resectabiliy: A case control study.通过计算机断层扫描测量食管胃交界腺癌的大体肿瘤体积以对应cT和cN分期，从而定量确定可切除性：一项病例对照研究。
Front Oncol. 2022 Nov 17;12:1038135. doi: 10.3389/fonc.2022.1038135. eCollection 2022.
4
Surgical Strategies for Siewert Type II Esophagogastric Junction Carcinomas: A Randomized Controlled Trial.Siewert II型食管胃交界部癌的手术策略：一项随机对照试验
Front Oncol. 2022 Jun 23;12:852594. doi: 10.3389/fonc.2022.852594. eCollection 2022.
5
Rare Abdominal Wall Metastasis following Curative Resection of Gastric Cancer: What Can Be Learned from the Use of Percutaneous Catheters?胃癌根治性切除术后罕见的腹壁转移：经皮导管的应用能带来哪些启示？
Case Rep Oncol Med. 2020 May 9;2020:3738798. doi: 10.1155/2020/3738798. eCollection 2020.
6
Prognostic value of resected lymph nodes numbers for Siewert II gastroesophageal junction cancer.Siewert II型胃食管交界部癌切除淋巴结数量的预后价值
Oncotarget. 2017 Dec 20;9(2):2797-2809. doi: 10.18632/oncotarget.23540. eCollection 2018 Jan 5.
7
Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum.胃食管交界腺癌的手术治疗方法：Siewert II型难题
Langenbecks Arch Surg. 2017 Dec;402(8):1153-1158. doi: 10.1007/s00423-017-1610-9. Epub 2017 Aug 12.
8
Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?胃食管结合部（AEG II）真正腺癌的手术策略：胸腹联合入路还是腹部入路？
Gastric Cancer. 2018 Mar;21(2):303-314. doi: 10.1007/s10120-017-0746-1. Epub 2017 Jul 6.
9
New evidence guiding extent of lymphadenectomy for esophagogastric junction tumor: Application of Ber-Ep4 Joint with CD44v6 staining on the detection of lower mediastinal lymph node micrometastasis and survival analysis.指导食管胃交界部肿瘤淋巴结清扫范围的新证据：Ber-Ep4联合CD44v6染色在检测下纵隔淋巴结微转移中的应用及生存分析
Medicine (Baltimore). 2017 Apr;96(14):e6533. doi: 10.1097/MD.0000000000006533.
10
Neoadjuvant vs. adjuvant treatment of Siewert type II gastroesophageal junction cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.新辅助治疗与辅助治疗对Siewert II型胃食管交界癌的疗效对比：基于监测、流行病学及最终结果（SEER）数据库的数据分析
J Gastrointest Oncol. 2016 Jun;7(3):403-10. doi: 10.21037/jgo.2015.10.06.
本文引用的文献
1
Multimodal treatment of gastrointestinal tract tumors: consequences for surgery.胃肠道肿瘤的多模式治疗：对手术的影响
World J Surg. 2005 Aug;29(8):940-8. doi: 10.1007/s00268-005-0010-4.
2
Neoadjuvant therapy for oesophagogastric cancer.食管癌和胃癌的新辅助治疗
Br J Surg. 2004 May;91(5):540-51. doi: 10.1002/bjs.4575.
3
A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.用于巴雷特食管及食管巴雷特腺癌分子诊断的多基因表达谱
Oncogene. 2004 Jun 10;23(27):4780-8. doi: 10.1038/sj.onc.1207663.
4
Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial.使用高分辨率内镜检查和高分辨率超声内镜对早期食管癌进行分期的准确性：一项对比性、前瞻性、双盲试验。
Gut. 2004 May;53(5):634-40. doi: 10.1136/gut.2003.029421.
5
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.18FDG PET及PET/CT肿瘤成像中的陷阱与伪影
Semin Nucl Med. 2004 Apr;34(2):122-33. doi: 10.1053/j.semnuclmed.2003.12.003.
6
Sentinel node detection in Barrett's and cardia cancer.
Ann Surg Oncol. 2004 Mar;11(3 Suppl):255S-8S. doi: 10.1007/BF02523640.
7
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment.食管鳞状细胞癌放化疗期间肿瘤代谢活性的时间进程及对治疗的反应
J Clin Oncol. 2004 Mar 1;22(5):900-8. doi: 10.1200/JCO.2004.07.122.
8
Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial.通过代谢成像预测胃癌术前化疗反应：一项前瞻性试验的结果
J Clin Oncol. 2003 Dec 15;21(24):4604-10. doi: 10.1200/JCO.2003.06.574.
9
Surgeon volume and operative mortality in the United States.美国外科医生手术量与手术死亡率
N Engl J Med. 2003 Nov 27;349(22):2117-27. doi: 10.1056/NEJMsa035205.
10
Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma.内镜超声检查作为食管癌长期生存预测指标的价值
Br J Surg. 2003 Nov;90(11):1367-72. doi: 10.1002/bjs.4307.
Zotero 插件